Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies
2019 · Cancer Cell · 1,057 citations
https://doi.org/10.1016/j.ccell.2019.02.001
Y
Yue Gong
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
73
Papers
3.9K
Citations
22
h-index
33
i10-index
Yue Gong is an academic researcher from Qingdao University. The author has contributed to research in topics: Breast Cancer Treatment Studies & Cancer Immunotherapy and Biomarkers & Hearing Loss and Rehabilitation. The author has an h-index of 22, co-authored 63 publications.
ORCID: 0000-0002-6842-5318Papers by this author
worksMetabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets
2020 · Cell Metabolism · 467 citations
https://doi.org/10.1016/j.cmet.2020.10.012
Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
2022 · Cell Research · 297 citations
https://doi.org/10.1038/s41422-022-00614-0
Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study
2017 · Scientific Reports · 242 citations
https://doi.org/10.1038/srep45411
Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential
2024 · Signal Transduction and Targeted Therapy · 161 citations
https://doi.org/10.1038/s41392-024-01771-x
Bulk and single-cell transcriptome profiling reveal the metabolic heterogeneity in human breast cancers
2021 · Molecular Therapy · 109 citations
https://doi.org/10.1016/j.ymthe.2021.03.003
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat